For members of the public:
Cyclizine
Overview
Teva markets Cyclizine. The Patient Information Leaflet for Cyclizine from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.
Date of preparation: April 2023
D: COB-GB-NP-00112 (V1.0) / T: COB-GB-NP-00102 (V1.0) / M: COB-GB-NP-00103 (V1.0)
Date of preparation: April 2023
D: COB-GB-00016 (V1.0) / T: COB-GB-00014 (V1.0) / M: COB-GB-00015 (V1.0)
Date of preparation: April 2023
D: COB-GB-NP-00104 (V1.0) / T: COB-GB-NP-00105 (V1.0) / M: COB-GB-NP-00106 (V1.0)